CAR T-Cell Therapy Market - Global Outlook and Forecast 2023-2028

Report ID: 1370502 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 CAR T-Cell Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global CAR T-Cell Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global CAR T-Cell Therapy Overall Market Size
    2.1 Global CAR T-Cell Therapy Market Size: 2021 VS 2028
    2.2 Global CAR T-Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top CAR T-Cell Therapy Players in Global Market
    3.2 Top Global CAR T-Cell Therapy Companies Ranked by Revenue
    3.3 Global CAR T-Cell Therapy Revenue by Companies
    3.4 Top 3 and Top 5 CAR T-Cell Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies CAR T-Cell Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 CAR T-Cell Therapy Players in Global Market
        3.6.1 List of Global Tier 1 CAR T-Cell Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global CAR T-Cell Therapy Market Size Markets, 2021 & 2028
        4.1.2 Allogeneic
        4.1.3 Autologous
    4.2 By Type - Global CAR T-Cell Therapy Revenue & Forecasts
        4.2.1 By Type - Global CAR T-Cell Therapy Revenue, 2017-2022
        4.2.2 By Type - Global CAR T-Cell Therapy Revenue, 2023-2028
        4.2.3 By Type - Global CAR T-Cell Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global CAR T-Cell Therapy Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Cancer Research Centers
        5.1.4 Others
    5.2 By Application - Global CAR T-Cell Therapy Revenue & Forecasts
        5.2.1 By Application - Global CAR T-Cell Therapy Revenue, 2017-2022
        5.2.2 By Application - Global CAR T-Cell Therapy Revenue, 2023-2028
        5.2.3 By Application - Global CAR T-Cell Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global CAR T-Cell Therapy Market Size, 2021 & 2028
    6.2 By Region - Global CAR T-Cell Therapy Revenue & Forecasts
        6.2.1 By Region - Global CAR T-Cell Therapy Revenue, 2017-2022
        6.2.2 By Region - Global CAR T-Cell Therapy Revenue, 2023-2028
        6.2.3 By Region - Global CAR T-Cell Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America CAR T-Cell Therapy Revenue, 2017-2028
        6.3.2 US CAR T-Cell Therapy Market Size, 2017-2028
        6.3.3 Canada CAR T-Cell Therapy Market Size, 2017-2028
        6.3.4 Mexico CAR T-Cell Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe CAR T-Cell Therapy Revenue, 2017-2028
        6.4.2 Germany CAR T-Cell Therapy Market Size, 2017-2028
        6.4.3 France CAR T-Cell Therapy Market Size, 2017-2028
        6.4.4 U.K. CAR T-Cell Therapy Market Size, 2017-2028
        6.4.5 Italy CAR T-Cell Therapy Market Size, 2017-2028
        6.4.6 Russia CAR T-Cell Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries CAR T-Cell Therapy Market Size, 2017-2028
        6.4.8 Benelux CAR T-Cell Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia CAR T-Cell Therapy Revenue, 2017-2028
        6.5.2 China CAR T-Cell Therapy Market Size, 2017-2028
        6.5.3 Japan CAR T-Cell Therapy Market Size, 2017-2028
        6.5.4 South Korea CAR T-Cell Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia CAR T-Cell Therapy Market Size, 2017-2028
        6.5.6 India CAR T-Cell Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America CAR T-Cell Therapy Revenue, 2017-2028
        6.6.2 Brazil CAR T-Cell Therapy Market Size, 2017-2028
        6.6.3 Argentina CAR T-Cell Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa CAR T-Cell Therapy Revenue, 2017-2028
        6.7.2 Turkey CAR T-Cell Therapy Market Size, 2017-2028
        6.7.3 Israel CAR T-Cell Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia CAR T-Cell Therapy Market Size, 2017-2028
        6.7.5 UAE CAR T-Cell Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Celgene (Juno Therapeutics)
        7.1.1 Celgene (Juno Therapeutics) Corporate Summary
        7.1.2 Celgene (Juno Therapeutics) Business Overview
        7.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Major Product Offerings
        7.1.4 Celgene (Juno Therapeutics) CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.1.5 Celgene (Juno Therapeutics) Key News
    7.2 Novartis
        7.2.1 Novartis Corporate Summary
        7.2.2 Novartis Business Overview
        7.2.3 Novartis CAR T-Cell Therapy Major Product Offerings
        7.2.4 Novartis CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.2.5 Novartis Key News
    7.3 Gilead (Kite Pharma)
        7.3.1 Gilead (Kite Pharma) Corporate Summary
        7.3.2 Gilead (Kite Pharma) Business Overview
        7.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Major Product Offerings
        7.3.4 Gilead (Kite Pharma) CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.3.5 Gilead (Kite Pharma) Key News
    7.4 Pfizer
        7.4.1 Pfizer Corporate Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer CAR T-Cell Therapy Major Product Offerings
        7.4.4 Pfizer CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.4.5 Pfizer Key News
    7.5 CARsgen Therapeutics
        7.5.1 CARsgen Therapeutics Corporate Summary
        7.5.2 CARsgen Therapeutics Business Overview
        7.5.3 CARsgen Therapeutics CAR T-Cell Therapy Major Product Offerings
        7.5.4 CARsgen Therapeutics CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.5.5 CARsgen Therapeutics Key News
    7.6 Autolus Therapeutics
        7.6.1 Autolus Therapeutics Corporate Summary
        7.6.2 Autolus Therapeutics Business Overview
        7.6.3 Autolus Therapeutics CAR T-Cell Therapy Major Product Offerings
        7.6.4 Autolus Therapeutics CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.6.5 Autolus Therapeutics Key News
    7.7 Aurora BioPharma
        7.7.1 Aurora BioPharma Corporate Summary
        7.7.2 Aurora BioPharma Business Overview
        7.7.3 Aurora BioPharma CAR T-Cell Therapy Major Product Offerings
        7.7.4 Aurora BioPharma CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.7.5 Aurora BioPharma Key News
    7.8 Sorrento Therapeutics
        7.8.1 Sorrento Therapeutics Corporate Summary
        7.8.2 Sorrento Therapeutics Business Overview
        7.8.3 Sorrento Therapeutics CAR T-Cell Therapy Major Product Offerings
        7.8.4 Sorrento Therapeutics CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.8.5 Sorrento Therapeutics Key News
    7.9 Mustang Bio
        7.9.1 Mustang Bio Corporate Summary
        7.9.2 Mustang Bio Business Overview
        7.9.3 Mustang Bio CAR T-Cell Therapy Major Product Offerings
        7.9.4 Mustang Bio CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.9.5 Mustang Bio Key News
    7.10 Bluebird Bio
        7.10.1 Bluebird Bio Corporate Summary
        7.10.2 Bluebird Bio Business Overview
        7.10.3 Bluebird Bio CAR T-Cell Therapy Major Product Offerings
        7.10.4 Bluebird Bio CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.10.5 Bluebird Bio Key News
    7.11 Collectis
        7.11.1 Collectis Corporate Summary
        7.11.2 Collectis Business Overview
        7.11.3 Collectis CAR T-Cell Therapy Major Product Offerings
        7.11.4 Collectis CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.11.5 Collectis Key News
    7.12 Allogene Therapeutics
        7.12.1 Allogene Therapeutics Corporate Summary
        7.12.2 Allogene Therapeutics Business Overview
        7.12.3 Allogene Therapeutics CAR T-Cell Therapy Major Product Offerings
        7.12.4 Allogene Therapeutics CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.12.5 Allogene Therapeutics Key News
    7.13 Celyad
        7.13.1 Celyad Corporate Summary
        7.13.2 Celyad Business Overview
        7.13.3 Celyad CAR T-Cell Therapy Major Product Offerings
        7.13.4 Celyad CAR T-Cell Therapy Revenue in Global Market (2017-2022)
        7.13.5 Celyad Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. CAR T-Cell Therapy Market Opportunities & Trends in Global Market
    Table 2. CAR T-Cell Therapy Market Drivers in Global Market
    Table 3. CAR T-Cell Therapy Market Restraints in Global Market
    Table 4. Key Players of CAR T-Cell Therapy in Global Market
    Table 5. Top CAR T-Cell Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global CAR T-Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global CAR T-Cell Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies CAR T-Cell Therapy Product Type
    Table 9. List of Global Tier 1 CAR T-Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 CAR T-Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global CAR T-Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global CAR T-Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - CAR T-Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global CAR T-Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global CAR T-Cell Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global CAR T-Cell Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa CAR T-Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Celgene (Juno Therapeutics) Corporate Summary
    Table 31. Celgene (Juno Therapeutics) CAR T-Cell Therapy Product Offerings
    Table 32. Celgene (Juno Therapeutics) CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Novartis Corporate Summary
    Table 34. Novartis CAR T-Cell Therapy Product Offerings
    Table 35. Novartis CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. Gilead (Kite Pharma) Corporate Summary
    Table 37. Gilead (Kite Pharma) CAR T-Cell Therapy Product Offerings
    Table 38. Gilead (Kite Pharma) CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer CAR T-Cell Therapy Product Offerings
    Table 41. Pfizer CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. CARsgen Therapeutics Corporate Summary
    Table 43. CARsgen Therapeutics CAR T-Cell Therapy Product Offerings
    Table 44. CARsgen Therapeutics CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. Autolus Therapeutics Corporate Summary
    Table 46. Autolus Therapeutics CAR T-Cell Therapy Product Offerings
    Table 47. Autolus Therapeutics CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. Aurora BioPharma Corporate Summary
    Table 49. Aurora BioPharma CAR T-Cell Therapy Product Offerings
    Table 50. Aurora BioPharma CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. Sorrento Therapeutics Corporate Summary
    Table 52. Sorrento Therapeutics CAR T-Cell Therapy Product Offerings
    Table 53. Sorrento Therapeutics CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. Mustang Bio Corporate Summary
    Table 55. Mustang Bio CAR T-Cell Therapy Product Offerings
    Table 56. Mustang Bio CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 57. Bluebird Bio Corporate Summary
    Table 58. Bluebird Bio CAR T-Cell Therapy Product Offerings
    Table 59. Bluebird Bio CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 60. Collectis Corporate Summary
    Table 61. Collectis CAR T-Cell Therapy Product Offerings
    Table 62. Collectis CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 63. Allogene Therapeutics Corporate Summary
    Table 64. Allogene Therapeutics CAR T-Cell Therapy Product Offerings
    Table 65. Allogene Therapeutics CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 66. Celyad Corporate Summary
    Table 67. Celyad CAR T-Cell Therapy Product Offerings
    Table 68. Celyad CAR T-Cell Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. CAR T-Cell Therapy Segment by Type in 2021
    Figure 2. CAR T-Cell Therapy Segment by Application in 2021
    Figure 3. Global CAR T-Cell Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global CAR T-Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global CAR T-Cell Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2021
    Figure 8. By Type - Global CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 12. US CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 24. China CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa CAR T-Cell Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE CAR T-Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Celgene (Juno Therapeutics) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novartis CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Gilead (Kite Pharma) CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. CARsgen Therapeutics CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Autolus Therapeutics CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Aurora BioPharma CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Sorrento Therapeutics CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Mustang Bio CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Bluebird Bio CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Collectis CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Allogene Therapeutics CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Celyad CAR T-Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
CAR T-Cell Therapy Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
CAR T-Cell Therapy Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
CAR T-Cell Therapy Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports